🔎 Trials Near Me

Beranda › Kardiomiopati › North Carolina

Uji klinis Kardiomiopati di North Carolina

7 studi untuk Kardiomiopati mencari peserta di lokasi di North Carolina.

Kota di North Carolina

Teks studi resmi (Bahasa Inggris)

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  • Clinical Trial Site, Charlotte
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07052903

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

  • Clinical Trial Site, Charlotte
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07358078

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

  • Duke University Hospital, Durham
Menerima pesertaFase 2
Usia 0 hingga 16 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06080074

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • Duke University Medical Center, Durham
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06563895

Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials

  • Duke Children's Hospital, Durham
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT07674758

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  • Duke University Medical Center, Durham
Menerima pesertaFase 3
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 27 Mar 2026 · NCT06128629

PKP2-ACM Natural History Study

  • Duke University, Durham
Menerima pesertaStudi observasional
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 27 Feb 2026 · NCT06644742

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.